Congress Targets Cannabis Exchange Listings With New Bipartisan Bill
New legislation would allow marijuana companies to list on NYSE and Nasdaq while protecting service providers from federal penalties.
A bipartisan congressional bill filed Wednesday directly addresses one of the cannabis industry's most persistent capital market barriers: access to major U.S. stock exchanges. The legislation would permit marijuana companies to list on the Nasdaq and New York Stock Exchange while extending federal protections to financial institutions, accountants, insurers, and other service providers working with cannabis businesses.
The move comes as cannabis companies face a $280 billion valuation discount compared to traditional sectors, largely due to banking restrictions and exchange limitations that force most operators onto over-the-counter markets or Canadian exchanges. Current federal prohibition creates a regulatory maze where even profitable cannabis companies like Curaleaf and Green Thumb Industries trade on secondary markets despite generating hundreds of millions in annual revenue.
Major exchange access would fundamentally reshape cannabis sector liquidity and institutional participation. Companies trading on OTC markets typically see 60-80% lower trading volumes than exchange-listed peers, directly impacting their ability to raise capital and execute acquisitions. The legislation addresses Section 280E tax burdens indirectly by legitimizing ancillary service relationships that currently operate in regulatory gray areas.
The timing aligns with broader federal cannabis policy momentum, including recent DEA scheduling review discussions and state-level legalization expansion. Twenty-four states now operate adult-use programs, creating a $30 billion legal market that remains largely disconnected from traditional capital markets. Exchange listings would likely trigger immediate institutional investor interest, particularly from pension funds and mutual funds currently prohibited from OTC cannabis exposure.
While passage remains uncertain given congressional dynamics, the bipartisan nature signals growing recognition of cannabis sector economic legitimacy. The legislation would create immediate winners among established operators with strong balance sheets positioned for institutional scrutiny, while potentially accelerating consolidation as smaller players gain access to public market capital for the first time.